Gyre Therapeutics (GYRE) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to $90.9 million.
- Gyre Therapeutics' Shares Outstanding rose 597.05% to $90.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.9 million, marking a year-over-year increase of 597.05%. This contributed to the annual value of $86.3 million for FY2024, which is 1267.95% up from last year.
- Gyre Therapeutics' Shares Outstanding amounted to $90.9 million in Q3 2025, which was up 597.05% from $90.8 million recorded in Q2 2025.
- Gyre Therapeutics' Shares Outstanding's 5-year high stood at $90.9 million during Q3 2025, with a 5-year trough of $31.3 million in Q1 2021.
- Over the past 5 years, Gyre Therapeutics' median Shares Outstanding value was $63.6 million (recorded in 2021), while the average stood at $62.9 million.
- As far as peak fluctuations go, Gyre Therapeutics' Shares Outstanding soared by 18775.74% in 2021, and later changed by 0.0% in 2022.
- Gyre Therapeutics' Shares Outstanding (Quarter) stood at $63.6 million in 2021, then changed by 0.0% to $63.6 million in 2022, then grew by 20.46% to $76.6 million in 2023, then increased by 12.68% to $86.3 million in 2024, then grew by 5.31% to $90.9 million in 2025.
- Its Shares Outstanding was $90.9 million in Q3 2025, compared to $90.8 million in Q2 2025 and $87.6 million in Q1 2025.